1Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab, 1998, 18(6): 583-609.
2Lutsep HL, Albets GW, De Crespigny A, et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol, 1997, 41 (5): 574-580.
3Albers GW. Diffusion-weighted MRI for evaluation of acute stroke.Neurology, 1998, 51 (Suppl 3): s47-49.
4Fisher M, Albers GW. Applications of diffusion-perffusion magnetic resonance imaging in acute ischemic stroke. Neurology, 1999, 52(9): 1750-1756.
5Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion and diffusion weighted MR1. Neurology, 1998, 51 (2): 418-426.
6Barber PA, Davis SM, Darby DG, et al. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology, 1999, 52 (6): 1125-1132.
7Nabavi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion: experimental validation and imtial clinical experience. Radiology, 1999, 213 (1): 141-149.
8Frykholm P, Andersson JLR, Valtysson J, et al. A metabolic threshokd of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion reperfusion primate model. Acta Neurol Scand,2000, 102(1): 18-26.
9Heiss WD, Kracht L, Grond M, et al. Early [11 C] flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy.Stroke, 2000, 31 (2): 366-369.
10Read S J, Hirano T, Abbott DE, et al. The fate of hypoxic tissue on18F fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol, 2000, 48(2): 228-235.
